# Mesoblast Ltd: financial statements, quarterly

MESO · Nasdaq · CIK 1345099 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/meso.md) · [Financials](/companies/meso/financials.md) · [Filings](/companies/meso/filings.md) · [Insiders](/companies/meso/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/meso/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2015-06-30) | period not labelled (2016-06-30) | period not labelled (2017-06-30) | FY2018 (2018-06-30) | FY2019 (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [111](/filings/0001564590-18-022521.md) | [80.9](/filings/0001564590-19-034304.md) | [45.8](/filings/0001564590-20-042401.md) | [37.8](/filings/0001564590-21-046486.md) | [50.4](/filings/0001564590-22-030576.md) | [129](/filings/0001345099-23-000059.md) | [137](/filings/0001345099-24-000063.md) | [60.4](/filings/0001345099-25-000067.md) | [71.3](/filings/0001345099-25-000067.md) | [63.0](/filings/0001345099-25-000067.md) | [162](/filings/0001345099-25-000067.md) |
| Current assets | $m | not reported | not reported | [63.6](/filings/0001564590-18-022521.md) | [101](/filings/0001564590-19-034304.md) | [62.5](/filings/0001564590-20-042401.md) | [137](/filings/0001564590-21-046486.md) | [148](/filings/0001564590-22-030576.md) | [69.8](/filings/0001345099-23-000059.md) | [81.7](/filings/0001345099-24-000063.md) | [86.5](/filings/0001345099-25-000067.md) | [204](/filings/0001345099-25-000067.md) |
| Total assets | $m | not reported | not reported | [656](/filings/0001564590-18-022521.md) | [692](/filings/0001564590-19-034304.md) | [652](/filings/0001564590-20-042401.md) | [734](/filings/0001564590-21-046486.md) | [745](/filings/0001564590-22-030576.md) | [662](/filings/0001345099-23-000059.md) | [669](/filings/0001345099-24-000063.md) | [669](/filings/0001345099-25-000067.md) | [785](/filings/0001345099-25-000067.md) |
| Current liabilities | $m | not reported | not reported | [36.7](/filings/0001564590-18-022521.md) | [24.0](/filings/0001564590-19-034304.md) | [44.3](/filings/0001564590-20-042401.md) | [90.1](/filings/0001564590-21-046486.md) | [94.3](/filings/0001564590-22-030576.md) | [51.4](/filings/0001345099-23-000059.md) | [42.0](/filings/0001345099-24-000063.md) | [73.2](/filings/0001345099-25-000067.md) | [103](/filings/0001345099-25-000067.md) |
| Total liabilities | $m | not reported | not reported | [139](/filings/0001564590-18-022521.md) | [146](/filings/0001564590-19-034304.md) | [171](/filings/0001564590-20-042401.md) | [184](/filings/0001564590-21-046486.md) | [163](/filings/0001564590-22-030576.md) | [165](/filings/0001345099-23-000059.md) | [168](/filings/0001345099-24-000063.md) | [189](/filings/0001345099-25-000067.md) | [187](/filings/0001345099-25-000067.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [53.2](/filings/0001564590-22-030576.md) | [5.0](/filings/0001564590-22-030576.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [468](/filings/0001564590-18-022521.md) | [528](/filings/0001564590-19-034304.md) | [517](/filings/0001564590-20-042401.md) | [546](/filings/0001564590-21-046486.md) | [481](/filings/0001564590-22-030576.md) | [549](/filings/0001345099-23-000059.md) | [581](/filings/0001345099-24-000063.md) | [497](/filings/0001345099-25-000067.md) | [502](/filings/0001345099-25-000067.md) | [480](/filings/0001345099-25-000067.md) | [597](/filings/0001345099-25-000067.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 1,296,862,776 at 2026-06-30, from the cover of the [20-F filed 2026-08-27](/filings/0001345099-26-000081.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.